Table 5.
Dengue seroconversion rate at the trial and control areas
| Area | Sex | Age (years) | No. at the 1st 1) | No. at the 2nd 2) | Seroconversion rate (%) |
|---|---|---|---|---|---|
| Trial |
Male |
2-5 |
1 |
0 |
0 |
| |
|
>5 |
15 |
12 |
80.0 |
| |
Female |
2-5 |
6 |
2 |
33.3 |
| |
|
>5 |
15 |
9 |
60.0 |
| Control |
Male |
2-5 |
2 |
1 |
50.0 |
| |
|
>5 |
34 |
25 |
73.5 |
| |
Female |
2-5 |
3 |
2 |
66.6 |
| >5 | 20 | 16 | 80.0 |
1) Number of samples negative for dengue IgG at the 1st blood collection.
2) Number of samples with seroconversion (i.e., positive for dengue IgG) at the 2nd blood collection.